Alert
Alert
By Jeffrey P. Metzler, Craig J. Saperstein, Roland C. Reimers,
03.28.20
The historic stimulus legislation signed into law on Friday makes available more than $14 billion in emergency funding for IHEs to prevent, prepare for, and respond to coronavirus. Funds may be used to defray expenses for IHEs, including lost revenue, technology costs associated with a transition to distance learning, and grants to students for food, housing, course materials, technology, health care and child care.
In addition, the Coronavirus Aid, Relief, and Economic Security (CARES) Act includes more than a dozen provisions aimed specifically at assisting students and IHEs struggling to cope with the enormous impact COVID-19 has had on campuses across the country (referred to as the “COVID–19 Pandemic Education Relief Act of 2020”). Some of the more noteworthy sections include:
- waiver of institutional requirements for the return of Title IV funds;
- waiver of student obligations to return Pell Grants and other grant assistance;
- cancellation of obligation to repay Federal Direct Loans; and
- relaxation of leave of absence rules.
Finally, the CARES Act includes many other components that may benefit IHEs (see overview of the Act here), such as major provisions addressing employment and healthcare, as well as economic development grants for which IHEs may be eligible. Leadership at IHEs should be mindful of these other elements as well when assessing the overall impact of the CARES Act on their institution.
For more information, please contact Jeffrey P. Metzler, Craig J. Saperstein, Barry D. Burgdorf, Roland C. Reimers, Sarah G. Flanagan or Jacob R. Sorensen.
Pillsbury’s experienced crisis management professionals are closely monitoring the global threat of COVID-19, drawing on the firm's capabilities in supply chain management, insurance law, cybersecurity, employment law, corporate law and other areas to provide critical guidance to clients in an urgent and quickly evolving situation. For more thought leadership on this rapidly developing topic, please visit our COVID-19 (Coronavirus) Resource Center.